Rani Therapeutics Holdings, Inc.
RANI
$0.84
-$0.03-3.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.88M | 3.17M | 1.63M | 1.20M | 1.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.88M | 3.17M | 1.63M | 1.20M | 1.20M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 4.88M | 3.17M | 1.63M | 1.20M | 1.20M |
| SG&A Expenses | 19.53M | 19.01M | 19.74M | 20.11M | 21.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.84M | 37.81M | 39.94M | 42.22M | 46.76M |
| Operating Income | -32.96M | -34.64M | -38.31M | -41.02M | -45.56M |
| Income Before Tax | -33.42M | -36.23M | -40.95M | -47.60M | -52.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.42 | -36.23 | -40.95 | -47.60 | -52.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.28M | 6.79M | 11.28M | 19.28M | 22.72M |
| Net Income | -30.14M | -29.44M | -29.67M | -28.32M | -29.69M |
| EBIT | -32.96M | -34.64M | -38.31M | -41.02M | -45.56M |
| EBITDA | -32.24M | -33.83M | -37.41M | -40.04M | -44.55M |
| EPS Basic | -0.35 | -0.49 | -0.67 | -0.79 | -0.91 |
| Normalized Basic EPS | -0.20 | -0.24 | -0.29 | -0.22 | -0.23 |
| EPS Diluted | -0.35 | -0.49 | -0.67 | -0.79 | -0.91 |
| Normalized Diluted EPS | -0.20 | -0.24 | -0.29 | -0.22 | -0.23 |
| Average Basic Shares Outstanding | 479.75M | 329.12M | 182.56M | 149.09M | 131.48M |
| Average Diluted Shares Outstanding | 479.75M | 329.12M | 182.56M | 149.09M | 131.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |